So by now I am certain everyone in the DTC genomics world has seen this BNET story
From the Story
"Is it really the best time for 23andMe, a leader in recreational genetic testing to be handing $4 million to an executive officer? That’s the news from their SEC filing. The official explanation is the $4 mm was a payback to a company officer for a loan, with the money coming from the company’s series B financing, which included an investment from Google. "
Ahem.......
Most people are running around spelling doom for 23andMe. I know, I have done it in the past
I have flayed them for playing doctor even begged my associates in the past to as well.
Listen, if anyone has a beef with these guys. I do. They had this thought to replace physicians, which is a foolish way to think. You cannot replace doctors. Just empower them. Which is what should have been done here, but instead they were too busy playing Doctor on Oprah and GMA......
But the question "Are these guys going under?" is a foolish question. Drew was right. They are not going under. They, just like ACORN are changing faces to try anew........
The industry is morphing here. They see that the only sustainable solution is partnered with health care practitioners is a smart way which benefits all, but most importantly, the patient....
The industry is morphing here. They see that the only sustainable solution is partnered with health care practitioners is a smart way which benefits all, but most importantly, the patient....
The Sherpa Says: The question should be, "What is this 4 million dollars for?"
1 comment:
my god I was a terrible writer back in 2008
Post a Comment